These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3908861)

  • 21. Dapsone resistance in leprosy.
    Browne SG
    Trans St Johns Hosp Dermatol Soc; 1973; 59(2):225-9. PubMed ID: 4602407
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of different regimens in multibacillary leprosy.
    Pattyn SR
    Lepr Rev; 1986; 57 Suppl 3():265-71. PubMed ID: 3553815
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative study of four rodent systems to monitor initial therapy of lepromatous leprosy: in search of a more sensitive system to assess bacterial viability.
    Gelber RH; Humphres RC; Fieldstell AH
    Acta Leprol; 1984; 2(2-4):319-25. PubMed ID: 6398591
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of multidrug therapy on the treatment and control of leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental chemotherapy in leprosy, then and now.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 27. Lepromatous leprosy: dapsone resistance.
    Barrett DF
    Proc R Soc Med; 1976 Jun; 69(6):391-2. PubMed ID: 959208
    [No Abstract]   [Full Text] [Related]  

  • 28. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
    Soga G; Blanc L; Alfa C; Grosset J; Xavier S
    Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of Hansen's disease.
    Trautman JR
    Cutis; 1976 Jul; 18(1):62-5. PubMed ID: 1017285
    [No Abstract]   [Full Text] [Related]  

  • 31. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
    Blanchy S; Galtier J
    Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
    [No Abstract]   [Full Text] [Related]  

  • 32. Clofazimine-resistant leprosy, a case report.
    Warndorff-van Diepen T
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):139-42. PubMed ID: 6749703
    [No Abstract]   [Full Text] [Related]  

  • 33. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 36. Leprosy and its chemotherapy.
    Beeching NJ; Ellis CJ
    J Antimicrob Chemother; 1982 Aug; 10(2):81-4. PubMed ID: 6749788
    [No Abstract]   [Full Text] [Related]  

  • 37. Dapsone syndrome--a case report.
    Khare AK; Bansal NK; Meena HS
    Indian J Lepr; 1987; 59(1):106-9. PubMed ID: 3611856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
    Freerksen E; Rosenfeld M
    Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
    Pattyn SR; Husser JA; Saint-André P
    Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.